Lataa...

Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application

The discovery that a number of aberrant tumorigenic processes and signal transduction pathways are mediated by druggable protein kinases has led to a revolutionary change in nonsmall cell lung cancer (NSCLC) treatment. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Med Oncol
Päätekijät: Maione, Paolo, Sacco, Paola Claudia, Sgambato, Assunta, Casaluce, Francesca, Rossi, Antonio, Gridelli, Cesare
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543855/
https://ncbi.nlm.nih.gov/pubmed/26327924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015595048
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!